Sign inGet started

Nazak Michael Adrian

Insider CIK 1799731 · ARDS Chief Financial Officer · ANTX Chief Accounting Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ANTX AN2 Therapeutics, Inc. A Award deriv2023-02-152023-02-1716,600— $016,600SEC↗
ANTX AN2 Therapeutics, Inc. A Award deriv2022-05-122022-05-1614,300— $014,300SEC↗
ARDS Aridis Pharmaceuticals, In M Exercise deriv2021-02-182021-02-2220,000— $080,000SEC↗
ARDS Aridis Pharmaceuticals, In M Exercise deriv2020-01-022020-01-1320,000— $060,000SEC↗